Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features

被引:1
作者
Tariq, Muhammad Usman [1 ]
Siddiqui, Muhammad Afnan [2 ]
Din, Nasir Ud [3 ]
Kayani, Naila [3 ]
机构
[1] Al Hada Armed Forces Hosp, Histopathol, Taif, Saudi Arabia
[2] Indus Hosp & Hlth Network, Histopathol, Karachi, Pakistan
[3] Aga Khan Univ Hosp, Pathol & Lab Med, Karachi, Pakistan
关键词
tumor infiltrating lymphocytes; immunohistochemistry; tnbc; triple negative breast cancer; sox10; MELANOCYTIC NEOPLASMS; CARCINOMA; FREQUENCY; UTILITY;
D O I
10.7759/cureus.59276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Triple -negative breast cancer (TNBC) poses a diagnostic challenge for histopathologists due to the reduced frequency of breast -specific markers. SOX10 has emerged as a useful diagnostic marker for TNBC. The aim of our study was to determine the frequency of SOX -10 immunohistochemical (IHC) expression in our cohort and assess its correlation with clinicopathological and histological features. Materials and methods: We included 72 primary TNBC cases. Specimens included tru-cut biopsies and excision specimens. We stained whole slide sections of these specimens with SOX10 antibody and calculated its frequency (%) of expression and H -score. We applied the chi-square test to assess the correlation between SOX10 expression and clinicopathological and histological features such as the patient's age, specimen type, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, tumor -infiltrating lymphocytes (TILs), necrosis, calcification, lymphovascular invasion (LVI), lymph node involvement, T stage, and N stage. Results: SOX10 expression was observed in 42 (58.3%) cases with a median H -score of 57.5. The expression was significantly higher in tru-cut biopsy specimens as compared to excision specimens (73.5 vs 41.7%) and TILs negative tumors as compared to TILs positive tumors (64.3% vs 27.3). Metaplastic carcinoma showed reduced expression when compared with non-metaplastic tumors (35.7% vs 63.8%), but statistical significance was not achieved. No correlation was observed with the patient's age, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, necrosis, calcification, LVI, lymph node involvement, T stage, and N stage. Conclusion: SOX10 was expressed in more than half of the TNBC cases of our study which not only highlights its diagnostic utility but advocated its application in combination with other breast -specific markers. The expression didn't correlate with the majority of clinicopathological and histological features, but correlation with tru-cut biopsy specimens and absence of TILs draws attention towards possible roles of proper fixation and host immunity, respectively.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors
    Ilieva, Nevena
    Pencheva, Mina
    Hadzhiev, Hristo
    Tashkova, Desislava
    Daskalova, Elena
    Georgiev, Petar
    Genova, Sylvia
    DIAGNOSTICS, 2024, 14 (23)
  • [42] Significance of AEG-1 Expression in Correlation With VEGF, Microvessel Density and Clinicopathological Characteristics in Triple-Negative Breast Cancer
    Li, Cong
    Li, Rui
    Song, Hongtao
    Wang, Dong
    Feng, Tian
    Yu, Xiaoguang
    Zhao, Yulan
    Liu, Junjun
    Yu, Xiaoyu
    Wang, Yanbo
    Geng, Jingshu
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (02) : 184 - 192
  • [43] Clinicopathological and immunohistochemical characteristics of breast cancer patients from Northeast India with special reference to triple negative breast cancer: A prospective study
    Sultana, Rizwana
    Kataki, Amal Ch
    Barthakur, Bibhuti Bhusan
    Sarma, Anupam
    Bose, Sujoy
    CURRENT PROBLEMS IN CANCER, 2020, 44 (05)
  • [44] Expression of C-myc and β-catenin and their correlation in triple negative breast cancer
    Wang, Jiankui
    Li, Mei
    Chen, Dedian
    Nie, Jianyun
    Xi, Yan
    Yang, Xiaojuan
    Chen, Yun
    Yang, Zhuanqing
    MINERVA MEDICA, 2017, 108 (06) : 513 - 517
  • [45] Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes
    An, Yeong Yi
    Kim, Sung Hun
    Kang, Bong Joo
    Park, Chang Suk
    Jung, Na Young
    Kim, Ji Youn
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (10) : 1894 - 1902
  • [46] Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
    da Silva, Jesse Lopes
    Rodrigues, Fabiana Resende
    de Mesquita, Guilherme Gomes
    Fernandes, Priscila Valverde
    Santos Thuler, Luiz Claudio
    de Melo, Andreia Cristina
    BREAST CANCER-TARGETS AND THERAPY, 2021, 13 : 31 - 44
  • [47] Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression
    Bae, Min Sun
    Park, So Yeon
    Song, Sung Eun
    Kim, Won Hwa
    Lee, Su Hyun
    Han, Wonshik
    Park, In-Ae
    Noh, Dong-Young
    Moon, Woo Kyung
    EUROPEAN RADIOLOGY, 2015, 25 (02) : 419 - 427
  • [48] Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
    Sun, Woo Young
    Lee, Yu Kyung
    Koo, Ja Seung
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [49] IF-7 and GALA modified PEG-PDMAEMA loaded SOX10 siRNA nanoparticles: Preparation, cellular delivery, and inhibition on progression of triple negative breast cancer and its bone metastasis in vitro
    Li, Bo
    Huang, Hong
    Du, Zixin
    Wang, Jing
    Gong, Yanling
    Wan, Xu
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 100
  • [50] Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients
    Sable, Mukund
    Pai, Trupti D.
    Shet, Tanuja
    Patil, Asawari
    Dhanavade, Sandeep
    Desai, Sangeeta B.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2017, 25 (03) : 230 - 237